Xeljanz XR 11 MG tablet UU 30S

Ended Awarded

Contract number
SPE2DB25FQVHU
Awardee
Awarding agency
Obligated
$5,772

Award facts

Contract value 100% obligated
$5,771.71 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency awarded a delivery order valued at $5,771.71 to AmerisourceBergen Drug Corp for XELJANZ XR 11 mg tablets (30-count units) on September 15, 2025, with completion scheduled for September 16, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. XELJANZ XR is a prescription immunosuppressant medication used primarily for rheumatoid arthritis and other inflammatory conditions, supporting the Department of Defense's pharmaceutical supply requirements for military and veteran healthcare systems.

This delivery order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a pharmaceutical prime vendor, AmerisourceBergen provides comprehensive global pharmaceutical support to military healthcare programs, including brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The company's federal contract portfolio demonstrates consistent capability to meet DLA's medical supply requirements through competitive procurement processes, serving customers including the Defense Health Agency and U.S. Coast Guard.

Quick answers

Who was awarded contract SPE2DB25FQVHU?

SPE2DB25FQVHU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 15, 2025.

How much is contract SPE2DB25FQVHU worth?

The government has obligated $5,772 on SPE2DB25FQVHU.

Is contract SPE2DB25FQVHU an order under another contract?

Yes. SPE2DB25FQVHU is a delivery order under SPE2DB25D3001, an indefinite delivery contract.

Was contract SPE2DB25FQVHU competed?

The extent of competition for SPE2DB25FQVHU was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award